RT Journal Article
T1 Assessing Adherence by Combining the Test of Adherence to Inhalers With Pharmacy Refill Records.
A1 Plaza, V
A1 Giner, J
A1 Curto, E
A1 Alonso-Ortiz, M B
A1 Orue, M I
A1 Vega, J M
A1 Cosio, B G
K1 Adherence to therapy
K1 Asthma
K1 COPD
K1 Nebulizer
K1 Patient compliance
K1 Self-reported success
AB The Global Initiative for Asthma (GINA) recommends the concurrent use of self-report and pharmacy refill data to assess treatment adherence. However, clinical evidence to support this combined approach is limited. Objective: To determine nonadherence to inhaler medication based on a validated questionnaire (Test of Adherence to Inhalers; TAI) and prescription refill data in a community sample of patients with chronic obstructive pulmonary disease (COPD) or asthma. Secondarily, we sought to determine the degree of concordance between these two measures. Cross-sectional, observational multicenter study in patients with asthma or COPD. Sociodemographic and clinical data were obtained from clinical records. Refill data were retrieved from electronic pharmacy databases. Participants completed the 12-item TAI during a single visit as part of routine care. Nonadherence was defined as TAI  A total of 816 patients (mean age, 60) were included. Nonadherence rates were 58.1% (TAI) and 28.6% (PRR) compared with 64.6% for the combined data (P These findings confirm the GINA recommendations, indicating that concomitant use of the TAI and pharmacy refill data identifies a higher percentage of nonadherent asthma or COPD patients than either instrument alone.
PB Esmon Publicidad
SN 1018-9068
YR 2019
FD 2019-10-08
LK http://hdl.handle.net/10668/15166
UL http://hdl.handle.net/10668/15166
LA en
NO Plaza V, Giner J, Curto E, Alonso-Ortiz MB, Orue MI, Vega JM, Cosío BG; et al. Assessing Adherence by Combining the Test of Adherence to Inhalers With Pharmacy Refill Records. J Investig Allergol Clin Immunol. 2021 Feb 17;31(1):58-64
DS RISalud
RD Apr 9, 2025